case_images: PMC3350165_01
case_images: Axial noncontrast CT section through the abdomen showing splenomegaly with multiple hyperdense nodules in the splenic parenchyma (arrowheads).
case_images: CRIM.ONCMED2011-298357.001.jpg
case_images: PMC3350165_01_CRIM.ONCMED2011-298357.001.jpg
case_images: fig1
case_images: Noncontrast CT abdomen showed massive splenomegaly with multiple hyperdense foci within the spleen (Figure 1, arrowheads) representing hemorrhage within the splenic parenchyma.
case_images: Lesions showing intense enhancement on post contrast CT images.
case_images: CRIM.ONCMED2011-298357.002.jpg
case_images: PMC3350165_01_CRIM.ONCMED2011-298357.002.jpg
case_images: fig2
case_images: Post contrast CT (Figure 2) revealed multifocal intensely enhancing areas in the splenic parenchyma suggesting the highly vascular nature of these masses.
case_images: Coronal postcontrast MR image showing splenomegaly with multiple intensely enhancing masses.
case_images: CRIM.ONCMED2011-298357.003.jpg
case_images: PMC3350165_01_CRIM.ONCMED2011-298357.003.jpg
case_images: fig3
case_images: On postcontrast MRI, there was central enhancement of these lesions (Figure 3) with intralesional traversing blood vessels (not shown).
case_images: Axial PET CT image showing FDG uptake in the lesions suggestive of high metabolic activity.
case_images: CRIM.ONCMED2011-298357.004.jpg
case_images: PMC3350165_01_CRIM.ONCMED2011-298357.004.jpg
case_images: fig4
case_images:  Bone marrow biopsy, however, revealed a B-cell lymphoma and an initial staging PET scan showed massively enlarged spleen with increased FDG uptake (Figure 4) with an SUV of 6.23 consistent with lymphoma or other malignant process.